Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN
1997-6933
(print)
ISSN
2500-2139
(online)
Register
Login
Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Clinical Oncohematology
Basic Research and Clinical Practice
ИФ РИНЦ:
0,587
H-INDEX:
16
Home
About the Journal
Aims and Scope
Editorial Board
Peer Review
Publishing Ethics and Malpractice Statement
Indexing and Abstracting
Ownership, management and funding
Open Access Policy and Publication Fee
Articles
Current
Journal pre-proofs
Archive
SUPPLEMENT
Sections
LYMPHOID TUMORS
MYELOID TUMORS
BONE MARROW TRANSPLANTATION
ANEMIAS
AUTOIMMUNE DISEASES
CLINICAL TRIALS
NOVEL CORONAVIRUS INFECTION
NEWS
NEW TECHNOLOGIES
REVIEWS
COMPLICATIONS OF CHEMOTHERAPY
PRACTICAL RECOMMENDATIONS
RARE HEMATOLOGICAL TUMORS AND SYNDROMES
EXPERIMENTAL STUDIES
Submission
Register
Login
Home
/
Search
Search
Search articles for
Advanced filters
Published After
Year
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
Year
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search
Search Results
##search.searchResults.foundPlural##
The Prognostic Value of ТР53 Gene Mutations in Patients with Cutaneous T-Cell Lymphomas
Liliya Gamilevna Gorenkova, B.V. Biderman, A.K. Smolianinova, E.E. Zvonkov
227-232
01.07.2025
Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome
Natal’ya Gennad’evna Chernova, O.A. Kolomeitsev
34-41
01.01.2018
Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome
Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev
366-371
01.07.2017
1 - 3 of 3 items
oa-antiplagiat
Make a Submission
Make a Submission
Banner ROHS
Indexing Databases
Editor-in-Chief
Gayane Sepugovna Tumyan
ARCHIVE
2026
Issue 1 (2026)
Issue 2 (2026)
Issue 3 (2026)
Issue 4 (2026)
2025
Issue 1 (2025)
Issue 2 (2025)
Issue 3 (2025)
Issue 4 (2025)
2024
Issue 1 (2024)
Issue 2 (2024)
Issue 3 (2024)
Issue 4 (2024)
2023
Issue 1 (2023)
Issue 2 (2023)
Issue 3 (2023)
Issue 4 (2023)
2022
Issue 1 (2022)
Issue 2 (2022)
Issue 3 (2022)
Issue 4 (2022)
2021
Issue 1 (2021)
Issue 2 (2021)
Issue 3 (2021)
Issue 4 (2021)
2020
Issue 1 (2020)
Issue 2 (2020)
Issue 3 (2020)
Issue 4 (2020)
2019
Issue 1 (2019)
Issue 2 (2019)
Issue 3 (2019)
Issue 4 (2019)
2018
Issue 1 (2018)
Issue 2 (2018)
Issue 3 (2018)
Issue 4 (2018)
2017
Issue 1 (2017)
Issue 2 (2017)
Issue 3 (2017)
Issue 4 (2017)
2016
Issue 1 (2016)
Issue 2 (2016)
Issue 3 (2016)
Issue 4 (2016)
2015
Issue 1 (2015)
Issue 2 (2015)
Issue 3 (2015)
Issue 4 (2015)
2014
Issue 1 (2014)
Issue 2 (2014)
Issue 3 (2014)
Issue 4 (2014)
2013
Issue 1 (2013)
Issue 2 (2013)
Issue 3 (2013)
Issue 4 (2013)
ALL ARCHIVE
Keywords
Most Read Articles
Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020
441
Materials of the II Conference “Current Issues of Diagnosis and Treatment of Ph-Negative and Ph-Positive Myeloproliferative Neoplasms” (March 15–16, 2019; National Research Center for Hematology, Moscow)
389
Obinutuzumab-Based Regimens in the First-Line Therapy for Follicular Lymphoma: Data from Real-World Clinical Practice in 41 Medical Institutions
379
Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
324
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
324
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
311
Pola-R-CHP Regimen as First-Line Therapy for Diffuse Large B-Cell Lymphoma: A Retrospective Study of Real-World Clinical Practice
243
Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
223
Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions
195
Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А
192
Up